Cue Biopharma, Inc. (CUE)
0.1799
-0.02
(-11.20%)
USD |
NASDAQ |
Apr 02, 16:00
0.1959
+0.02
(+8.89%)
After-Hours: 20:00
Cue Biopharma EPS Diluted (Quarterly) : 0.0143 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1341 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
| Imunon, Inc. | -1.292 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.585M |
| Revenue (Quarterly) | 21.94M |
| Total Expenses (Quarterly) | 20.36M |
| Enterprise Value | -5.370M |
| Gross Profit Margin (Quarterly) | 85.39% |
| Profit Margin (Quarterly) | 7.22% |
| Earnings Yield | -174.2% |
| Normalized Earnings Yield | -174.21 |